CN106866559A - 雷西纳得的共晶及其制备方法 - Google Patents
雷西纳得的共晶及其制备方法 Download PDFInfo
- Publication number
- CN106866559A CN106866559A CN201710052927.3A CN201710052927A CN106866559A CN 106866559 A CN106866559 A CN 106866559A CN 201710052927 A CN201710052927 A CN 201710052927A CN 106866559 A CN106866559 A CN 106866559A
- Authority
- CN
- China
- Prior art keywords
- bases
- bromo
- cocrystallizing type
- acetic acid
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710052927.3A CN106866559B (zh) | 2013-12-20 | 2014-12-17 | 雷西纳得的共晶及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310706091.6A CN103626710A (zh) | 2013-12-20 | 2013-12-20 | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1,2,4-三唑-3-基硫基)乙酸的共晶及其制备方法 |
CN201710052927.3A CN106866559B (zh) | 2013-12-20 | 2014-12-17 | 雷西纳得的共晶及其制备方法 |
CN201410783346.3A CN104529919B (zh) | 2013-12-20 | 2014-12-17 | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的共晶及其制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410783346.3A Division CN104529919B (zh) | 2013-12-20 | 2014-12-17 | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的共晶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106866559A true CN106866559A (zh) | 2017-06-20 |
CN106866559B CN106866559B (zh) | 2019-05-17 |
Family
ID=50208201
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310706091.6A Pending CN103626710A (zh) | 2013-12-20 | 2013-12-20 | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1,2,4-三唑-3-基硫基)乙酸的共晶及其制备方法 |
CN201710052927.3A Expired - Fee Related CN106866559B (zh) | 2013-12-20 | 2014-12-17 | 雷西纳得的共晶及其制备方法 |
CN201410783346.3A Expired - Fee Related CN104529919B (zh) | 2013-12-20 | 2014-12-17 | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的共晶及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310706091.6A Pending CN103626710A (zh) | 2013-12-20 | 2013-12-20 | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1,2,4-三唑-3-基硫基)乙酸的共晶及其制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410783346.3A Expired - Fee Related CN104529919B (zh) | 2013-12-20 | 2014-12-17 | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的共晶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN103626710A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019001325A1 (zh) * | 2017-06-28 | 2019-01-03 | 苏州科睿思制药有限公司 | 雷西纳得的晶型xv及其制备方法 |
CN115838343A (zh) * | 2022-11-22 | 2023-03-24 | 天津大学 | 一种贝利司他-l-脯氨酸两性离子共晶及其制备方法和应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104557748A (zh) * | 2014-01-25 | 2015-04-29 | 广东东阳光药业有限公司 | 硫代-1,2,4-三唑衍生物的新的固体形态 |
CN105294585B (zh) * | 2014-07-02 | 2019-02-12 | 成都海创药业有限公司 | 一种治疗痛风的化合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101443328A (zh) * | 2006-04-05 | 2009-05-27 | 安斯泰来制药有限公司 | C-糖苷衍生物和l-脯氨酸的共结晶体 |
CN101918377A (zh) * | 2007-11-27 | 2010-12-15 | 亚德生化公司 | 新颖化合物和组合物以及使用方法 |
CN102036946A (zh) * | 2008-05-21 | 2011-04-27 | 埃斯蒂文博士实验室股份有限公司 | 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体 |
CN103298796A (zh) * | 2010-12-30 | 2013-09-11 | 阿迪亚生命科学公司 | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1,2,4-三唑-3-基硫基)乙酸的多晶型形式及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG182404A1 (en) * | 2010-01-08 | 2012-08-30 | Ardea Biosciences Inc | Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
-
2013
- 2013-12-20 CN CN201310706091.6A patent/CN103626710A/zh active Pending
-
2014
- 2014-12-17 CN CN201710052927.3A patent/CN106866559B/zh not_active Expired - Fee Related
- 2014-12-17 CN CN201410783346.3A patent/CN104529919B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101443328A (zh) * | 2006-04-05 | 2009-05-27 | 安斯泰来制药有限公司 | C-糖苷衍生物和l-脯氨酸的共结晶体 |
CN101918377A (zh) * | 2007-11-27 | 2010-12-15 | 亚德生化公司 | 新颖化合物和组合物以及使用方法 |
CN102036946A (zh) * | 2008-05-21 | 2011-04-27 | 埃斯蒂文博士实验室股份有限公司 | 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体 |
CN103298796A (zh) * | 2010-12-30 | 2013-09-11 | 阿迪亚生命科学公司 | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1,2,4-三唑-3-基硫基)乙酸的多晶型形式及其用途 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019001325A1 (zh) * | 2017-06-28 | 2019-01-03 | 苏州科睿思制药有限公司 | 雷西纳得的晶型xv及其制备方法 |
CN115838343A (zh) * | 2022-11-22 | 2023-03-24 | 天津大学 | 一种贝利司他-l-脯氨酸两性离子共晶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104529919B (zh) | 2018-04-06 |
CN104529919A (zh) | 2015-04-22 |
CN106866559B (zh) | 2019-05-17 |
CN103626710A (zh) | 2014-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104529919B (zh) | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的共晶及其制备方法 | |
CN105801653B (zh) | 奥贝胆酸的晶型a及其制备方法 | |
CN107848979A (zh) | 乐伐替尼甲磺酸盐的新晶型及其制备方法 | |
CN104447590B (zh) | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的晶型及其制备方法 | |
de Diego et al. | Formation of solid solutions between racemic and enantiomeric citalopram oxalate | |
WO2005005956A2 (en) | Fluorophore compounds and their use in biological systems | |
CN104478815B (zh) | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸的多种盐、它们的晶型及其制备方法 | |
Ahuja et al. | Study of three solvates of sulfamethazine | |
Torres-Moya et al. | High thermal stability, pH responsive organogels of 2 H-benzo [d] 1, 2, 3-triazole derivatives as pharmaceutical crystallization media | |
CN109336823B (zh) | 一种替硝唑药物共晶及其制备方法 | |
CN104387333B (zh) | 2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4h‑1,2,4‑三唑‑3‑基硫基)乙酸钠的晶型及其制备方法 | |
CN109776430B (zh) | 一种磺胺二甲嘧啶共晶及其制备方法 | |
CN106188222A (zh) | 一种双二肽结构超分子凝胶因子及其制备方法 | |
CN108358904A (zh) | 一种阿齐沙坦与4,4’-联吡啶的共晶体及其制备方法 | |
CN104945307B (zh) | 苯并吲哚盐类材料、其非线性光学晶体、制备方法和用途 | |
CN106892900A (zh) | 一种富马酸沃诺拉赞及其制备方法 | |
CN108558791A (zh) | 一种乙酰唑胺与脯氨酸的共晶及其制备方法 | |
CN106831620A (zh) | 雷西纳得的晶型及其制备方法 | |
Cao et al. | Formation and regulation of supramolecular chirality in organogel via addition of tartaric acid | |
JP7326295B2 (ja) | オキサゾール化合物結晶 | |
JP7051968B2 (ja) | オキサゾール化合物結晶 | |
Jain et al. | A facial microwave-assisted synthesis, spectroscopic characterization and preliminary complexation studies of calix [4] pyrroles containing the hydroxamic-acid moiety | |
CN104379562B (zh) | 4-(3-苄氧基苯基硫基)-2-氯-1-(3-硝基丙基)苯晶体 | |
EP2499133A2 (en) | Process for the preparation of crystalline form i of l-malic acid salt of sunitinib | |
Etter et al. | Synthesis, spectroscopic and structural perspective of new ferrocenyl amides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 215123 Biological Park B4, No. 218 Xing Hu Street, Suzhou Industrial Park, Jiangsu Applicant after: CRYSTAL PHARMATECH Co.,Ltd. Applicant after: SUZHOU PENGXU PHARMATECH Co.,Ltd. Address before: 215123 Biological Park B4, No. 218 Xing Hu Street, Suzhou Industrial Park, Jiangsu Applicant before: Crystal Pharmatech Co.,Ltd. Applicant before: SUZHOU PENGXU PHARMATECH Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190517 Termination date: 20211217 |
|
CF01 | Termination of patent right due to non-payment of annual fee |